Dr. John Cush RheumNow
6 years 9 months ago
Study of 1054 adults with septic bone, joint, prosthetic infections shows that 6 weeks of oral antibiotic therapy cost less and was noninferior to IV antibiotic therapy (success rate ~85% at 1 year) while being >20% cheaper https://t.co/MYNxAWT1GT
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW MMF maybe an alternative to MTX, but only has observational evidence https://t.co/6yzFCdgE6S
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW shoes data that MTX works in SSc https://t.co/CzOmeg2ant
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW says limited SSc has slowly progressive skin thickening of the distal extremities but also the face and neck.
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW says the telangiectasias of CREST are usually a late, not early, finding
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW says Raynauds, puffy digits and a +ANA should raise suspicion of systemic sclerosis. Also Carol tunnel syndrome may be a presenting feature
Dr. John Cush RheumNow
6 years 9 months ago
Dr. Heidi Jacobi #UTSW lecturing on scleromyxedema often with "pebble like" lesions that during it from scleroderma https://t.co/5odVXrglyT
Dr. John Cush RheumNow
6 years 9 months ago
#UTSW Rheumatology grand rounds with Dr Heidi Jacobi . Serologic and lab findings in patients with MOPHEA https://t.co/d619QnYrZ9
Dr. John Cush RheumNow
6 years 9 months ago
Toscana is an arbovirus transmitted by sand flies in the Mediterranean. May fever, neuroinvasive infections & is an important cause of meningitis and encephalitis. May also cause Guillain-Barré, myositis, fasciitis, polymyeloradiculopathy, deafness, https://t.co/9X4OwAqRF9
Highlights from Tuesday, day 3 of the ACR Annual meeting in Chicago, included the PEXIVAS Study, ACR Reproductive Health Draft Guidelines, and a Proof of concept study
2019 was a year marked by major advances, hallmark research, and big news items affecting rheumatology. Herein you will find our top 10 list, formulated by what I think rheumatologists should know and what will likely change their standards and practice in 2020 and beyond.
Dr. John Cush RheumNow
6 years 9 months ago
Misuse and abuse of Gabapentin in US? Between 2003-2016 there were 260 million gabapentinoid visits. Annual use nearly quadrupled from 2003 to 2016 (mostly PCPs 46%). Nearly half w/ concurrent opioids (32.9%) or benzodiazepines (15.3%). https://t.co/Wnja1mkDQo
Dr. John Cush RheumNow
6 years 9 months ago
Systematic literature of biologic Rx of dactylitis & enthesitis in Psoriatic arthritis. 18 trials, 6981 patients showed that TNF inhib & ustekinumab, secukinumab, ixekizumab were 2-3 fold significantly better than PBO at resolution of dactylitis by Wk 24. https://t.co/HlQcw5cXsN
Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee. The ACR periodically updates guidelines to reflect any advances in management added to the literature since the last publication, which in this case was 2012.
Dr. John Cush RheumNow
6 years 9 months ago
301 fibromyalgia #FM pts randomized to receive active‐TENS or placebo‐TENS or no‐TENS to use at home 2h/day for 4 wks. Active TENS had greater reduction in pain & fatigue vs placeboAND better global improvement (70% vs. 31%, p<0.0001) https://t.co/AH84DxlTo3
